-
Founded in:
2004-03-09 -
Country:
China -
Address:
No. 279 Nanhai Avenue, Haikou City -
Tax NO.:
914601007543894388 -
Registered Funds:
194.8706 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Trimetazidine dihydrochloride |
|
13171-25-0 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Bisoprolol fumarate |
Pharmacological action not specified
More
Pharmacological action not specified |
104344-23-2 | 47 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Loratadine |
It is a long-acting tricyclic antihistamine that can relieve nasal or non-nasal symptoms of seasonal allergic rhinitis by selectively antagonizing peripheral H1 receptors.
More
It is a long-acting tricyclic antihistamine that can relieve nasal or non-nasal symptoms of seasonal allergic rhinitis by selectively antagonizing peripheral H1 receptors. |
10mg | 79794-75-5 | 61 |
| Pseudoephedrine sulfate |
It is an adrenaline-mimetic drug that can constrict the blood vessels of the nasal mucosa and relieve symptoms of nasal congestion and runny nose.
More
It is an adrenaline-mimetic drug that can constrict the blood vessels of the nasal mucosa and relieve symptoms of nasal congestion and runny nose. |
248mg | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fexofenadine hydrochloride |
Extract from the above information
More
Extract from the above information |
153439-40-8 | 49 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Alendronate sodium |
This product is a bone metabolism regulator, an aminobisphosphonate, which has a strong affinity with hydroxyapatite in the bone. It can enter the hydroxyapatite crystals in the bone matrix. When osteoclasts dissolve the crystals, the drug is released, which can inhibit the activity of osteoclasts and indirectly inhibit bone resorption through osteoblasts. It is characterized by strong anti-bone resorption activity and no bone mineralization inhibition.
More
This product is a bone metabolism regulator, an aminobisphosphonate, which has a strong affinity with hydroxyapatite in the bone. It can enter the hydroxyapatite crystals in the bone matrix. When osteoclasts dissolve the crystals, the drug is released, which can inhibit the activity of osteoclasts and indirectly inhibit bone resorption through osteoblasts. It is characterized by strong anti-bone resorption activity and no bone mineralization inhibition. |
121268-17-5 | 38 |